Tingnan ang Post

Efficacy, Safety, and Tolerability ng Etravirine With and without Darunavir/Ritonavir o Raltegravir in Treatment-Experienced Patient: Pagsusuri ng Etravirine Early Access Program sa United States. Journal of Acquired Immune Deficiency Syndrome, 53(5): 614-618.

Sa pamamagitan ng AHFAbril 1, 2010